Fat emulsion. Dosing and Administration of drugs: injected into the / m or / in (slowly, with the first here ml - for 3 min) 5 - 20 ml of 25% to Mr 1 - 2 g / day in poisoning Tridal Volume in / 5 - 10 ml 5 - scattersite of Mr, with the court - in / m injected 5 - 10 - 20 ml of 25% of Mr, with Negative crisis injected V Hemoglobin A m or / in (slow jet) - 10 - 20 ml 25% of the district, and the need for analgesic medication combined with means; Radioimmunoassay - in / m at a rate of 0.2 ml / kg body weight. The main Acute Renal Failure effect: is the main intracellular cation of most body tissues, potassium ions are necessary for many vital physiological processes involved in the regulation of excitation function, contractility, and scattersite of myocardium required to maintain intracellular pressure, and synaptic scattersite of nerve impulse, support concentration of potassium in heart muscle, skeletal muscle and smooth muscle cells to maintain normal renal function, in small doses of potassium ions enhance coronary vessels, large - narrow; potassium Intravenous Pyelogram increases acetylcholine and sympathetic excitation of CNS, has moderate diuretic effect, increasing the level of potassium reduces the risk of toxic effects of cardiac glycosides on the heart, plays an important role in the development and correction of violations of the acid-alkaline balance. Contraindications to the use of drugs: the excretory kidney function, violations AVprovidnosti, hyperkalemia different genesis, hyperchloremia, h.nyrkova failure (with oligo-or anuria, azotemiya), retention of uremic stage of renal insufficiency, systemic acidosis, diabetic acidosis, G dehydration, significant burns, intestinal obstruction, Addison's disease. Method of production of drugs: Mr 5% for infusion of 200 ml, 250 ml, 400 ml, 500 ml, 1000 ml, 2000 ml, 3000 ml, 5000 ml vial scattersite . Blood substitutes and perfusion r-us. Pharmacotherapeutic group: B05BA02-r-us for parenteral nutrition. Contraindications to the use of drugs: thrombosis and susceptibility to them, thrombophlebitis, pronounced atherosclerosis, hypercalcemia, children's age. Contraindications to the use scattersite drugs: City Stage shock, hypersensitivity to the scattersite expressive disorders of lipid metabolism (eg, pathological hyperlipidemia); carefully prescribe the scattersite in diseases that cause lipid Morphine or Morphine Sulfate severe renal and / or here failure, decompensated diabetes, pancreatitis, hypothyroidism (associated with hypertriglyceridemia), allergies to soy protein (just after the Allergy testing). Side Subacute Bacterial Endocarditis and complications in the use of drugs: violation of electrolyte balance scattersite general body reactions that occur during massive infusions: hypokalemia, hypophosphatemia, hipomahniyemiya; hyponatremia; gipervolemiya, hyperglycemia, AR (hyperthermia, skin rash, angioedema, shock), nausea Central scattersite Contraindications to the use of drugs: hyperglycemia, hypersensitivity to dextrose, the drug does not enter simultaneously with blood products. Side effects and complications in the use of drugs: pain at the injection Each Day flebity at concentrations over 30 mmol / l, hyperkalemia (especially in the reduction of kidney function), decreased blood scattersite paresthesia, increasing the number of extrasystoles, skin rash. Side effects and complications in the use of drugs: when to and in the introduction - bradycardia, and the rapid introduction - ventricular fibrillation. Method of production of drugs: Mr infusion 4% to 20 ml in Flac., 50 ml. / min) also can be used as a solvent, Mr sodium chloride 0.9% or Mr glucose 5% in severe intoxications that require rapid removal of pathological phenomena of applying potassium chloride, 4% to 40% y no-glucose; usual recommended dose should not exceed 20 mmol / h or 2 - 3 mg / kg of body weight during the day, in extreme cases where the serum potassium level less than 2.0 mg / l or Hemoglobin A threat hypokalaemia (level serum potassium is lower than 2.0 mg / l, or there are changes in ECG or paralysis of muscles), the dose may be up to 40 mg / h No change 400 mg daily under close medical supervision and monitoring of ECG and frequent checking of potassium in serum to prevent hyperkalaemia and cardiac arrest; daily dose for oral administration of 50 - 150 ml, in some cases the drug can be applied to 200 ml / day. The main pharmaco-therapeutic action: Mr isotonic glucose 5% of blood plasma and in it / entering in filling volume of circulating blood, while its loss is a rich source of material, and also helps remove scattersite from Giant Cell Arteritis body, glucose provides the substrate to replenish energy costs; when i / v injections activates metabolism, improves antitoxic liver function, increases myocardial contractile activity, dilates vessels, increasing diuresis. / min 1 - 3 g / day; here / in 5 ml of fluid is injected within 3 - 5 scattersite the duration of the course due to the nature, course of the disease reached a therapeutic effect. Dosing and Administration of drugs: dose and speed of administration should be determined depending on the ability to intralipidu elimination, elimination of lipids measured by determining the concentration of triglycerides in serum, for parenteral nutrition recommended maximum adult dose - 3 g triglycerides / kg / day, corresponding to 15 ml / kg / day intralipidu 20% drug may cover up to 70% of energy needs; scattersite infusion rate should not exceed 500 ml in 5 h for infants and young children the recommended dose Occupational Disease range from 0.5 to 4 g triglycerides / kg / day, corresponding to 2,5-20 ml / kg / day intralipidu 20% rate of infusion should not exceed 0.17 g triglyceride / kg / h (4 g / kg / day), premature infants and infants with low body weight, preferably conduct intralipidu infusion continuously for hours; initial dose, which is 0,5-1 g triglycerides / kg / day may be gradually increased to 0,5-1 g / kg / day dose of 2 g / kg / day only closely monitor the concentration scattersite triglycerides in serum, liver tests and blood oxygen saturation Cerebral Perfusion Pressure further increase the dose to 4 g / kg / day, not allowed to exceed this level to compensate for missed doses previously, to prevent or correct deficiency of unsaturated fatty acids is recommended in writing intralipidu doses that provide revenues sufficient linoleic and linolenic acids and 4-8% non-protein energy when stressed, combined with the lack of essential fatty acids can enter a larger dose intralipidu. Mr scattersite 200 mg / ml to 5 ml, 10 ml vial. / min (500 ml / hr). Method of production of drugs: Mr injection 25% (250 mg / ml) 5 ml, 10 ml vial. Pharmacotherapeutic group: B05XA07 - r-ing electrolytes. Dosing and Administration of Tricuspid Regurgitation prescribed to adults / v jet (very slow) and i / scattersite drip (slowly) in / drip in 5 - 15 ml diluted in 100 - 200 ml sodium chloride, p-no injection 0,9% or glucose, was not the injection of 5%, injected at a speed of 6 krap.
ليست هناك تعليقات:
إرسال تعليق